Cargando…
Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis
BACKGROUND: Pulmonary Langerhans cell histiocytosis (PLCH) is a rare disorder characterised by granulomatous proliferation of CD1a-positive histiocytes forming granulomas within lung parenchyma, in strong association with tobacco smoking, and which may result in chronic respiratory failure. Smoking...
Autores principales: | Grobost, Vincent, Khouatra, Chahera, Lazor, Romain, Cordier, Jean-François, Cottin, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268858/ https://www.ncbi.nlm.nih.gov/pubmed/25433492 http://dx.doi.org/10.1186/s13023-014-0191-8 |
Ejemplares similares
-
Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis
por: Nasser, Mouhamad, et al.
Publicado: (2018) -
Cladribine and cytarabine in children refractory high risk multisystem Langerhans cell histiocytosis
por: Wang, Wenqian, et al.
Publicado: (2023) -
Pulmonary hypertension in chronic lung diseases: comparison to other pulmonary hypertension groups
por: Chebib, Nader, et al.
Publicado: (2018) -
Right-to-left shunt with hypoxemia in pulmonary hypertension
por: Vodoz, Jean-Frédéric, et al.
Publicado: (2009) -
Pulmonary langerhans cell histiocytosis
por: Suri, Harpreet S, et al.
Publicado: (2012)